Biogen (NASDAQ:BIIB) announced the appointment of Michael Ehlers, M.D., Ph.D., as executive vice president, Research and Development. Dr. Ehlers will oversee Biogen’s global Research, Drug Discovery, Clinical Development, and Medical Affairs functions, defining the strategic direction for the company’s R&D organization and leading its efforts to develop therapies for patients with few or no treatment options. Dr. Ehlers will report to George Scangos, Ph.D., chief executive officer, and will be a member of the Biogen management team. He will begin his tenure at Biogen in late May.
Biogen Inc. (NASDAQ:BIIB) belongs to Healthcare sector. Its net profit margin is 34.30% and weekly performance is 5.33%. On last trading day company shares ended up at $280.06.
On April 11, 2016, Veronica G.H. Jordan, Ph.D. informed the Board of Directors of Albany Molecular Research, Inc. (NASDAQ:AMRI) that she will not stand for re-election when her current term expires at the Company’s 2016 Annual Meeting of Stockholders due to her intention to retire from the Board of Directors, the Compensation Committee of the Board of Directors and the Audit Committee of the Board of Directors, effective June 1, 2016, in order to devote further time and attention to her other business ventures. Dr. Jordan’s decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Albany Molecular Research Inc. (NASDAQ:AMRI) shares fell -0.89% in last trading session and ended the day at $15.60. AMRI Gross Margin is 26.40% and its return on assets is -0.30%. Albany Molecular Research Inc. (NASDAQ:AMRI) quarterly performance is -2.50%.
On 27 April, Famous Dave’s of America Inc. (NASDAQ:DAVE) shares increased 0.51% and was closed at $5.96. DAVE EPS growth in last 5 year was -28.40%. Famous Dave’s of America Inc. (NASDAQ:DAVE) year to date (YTD) performance is -14.12%.
MSCI Inc. (NYSE: MSCI) announced that Kathleen Winters will join the firm as Chief Financial Officer on May 2, 2016. She will succeed Bob Qutub, who is retiring from the firm.
MSCI Inc. (NYSE:MSCI) ended the last trading day at $76.36. Company weekly volatility is calculated as 1.28% and price to cash ratio as 9.63. MSCI Inc. (NYSE:MSCI) showed a weekly performance of 1.06%.
SJW Corp. (NYSE:SJW) reported financial results for the first quarter ended March 31, 2016. Operating revenue was $61.1 million in the quarter compared to $62.1 million in 2015. The $1.0 million decrease in revenue was primarily attributable to $6.5 million in lower customer usage and $1.8 million in true-up revenue recognized as a part of the 2012.
SJW Corp. (NYSE:SJW) shares fell -1.27% in last trading session and ended the day at $36.60. SJW Gross Margin is 87.80% and its return on assets is 2.90%. SJW Corp. (NYSE:SJW) quarterly performance is 20.84%.